Rigetti Computing vs. IonQ: Which Quantum Computing Stock Has Better Revenue Momentum?

Rigetti and IonQ remain highly speculative quantum computing stocks, but the article argues IonQ is the better buy thanks to higher expected revenue growth, stronger government-contract momentum, and more advanced trapped-ion technology. Analysts expect Rigetti revenue to rise from $7 million in 2025 to $100 million in 2028, while IonQ revenue is projected to increase from $130 million to $638 million over the same period. Both stocks are unprofitable and expensive at 28x and 32x 2028 sales, respectively, limiting near-term upside despite long-term market growth potential.

Analysis

The market is treating “quantum” as one theme, but the article actually implies two very different balance-sheet and commercialization paths. IonQ’s government-heavy revenue mix matters because public-sector spend is the only quantum demand source with enough budget tolerance to subsidize imperfect hardware today; that makes IONQ less dependent on early enterprise adoption cycles and gives it a cleaner funding runway than RGTI. Second-order effect: if federal procurement becomes the anchor customer set, smaller private vendors and systems integrators can get crowded out, while cloud-distribution platforms and defense-adjacent partners capture more of the ecosystem value.

Rigetti’s implied upside is more levered to hardware execution, but that is also where the stock’s risk is underappreciated. A move from prototype to repeatable 1,000+ qubit systems is not a revenue story first; it is a manufacturing yield story, and any slip by even 6-12 months would push the valuation multiple into the penalty box because the market is already discounting a steep growth ramp. IonQ’s accuracy-first architecture looks less flashy, but it is more likely to win the first budgeted workloads where error tolerance, not qubit count, is the gating factor.

The consensus may be underestimating how long these names can remain “optionality stocks” rather than fundamentals stocks. The current setup rewards momentum until one of two things breaks: either order intake fails to convert into recurring platform usage, or capital markets tighten and force another dilution cycle. In that regime, the higher-quality revenue mix and government backlog make IONQ the better relative long, while RGTI is more vulnerable to a sharp de-rating if the next hardware milestone is perceived as incremental rather than transformational.

For us, the real edge is not owning the theme outright, but expressing dispersion between commercialization credibility and hardware-execution risk. The clearest setup is to stay constructive on IONQ on pullbacks and avoid chasing RGTI into momentum spikes unless there is a confirmed contract or technical milestone that changes the revenue curve, not just the qubit headline.

Key Decisions for Investors

• Long IONQ on 10-15% pullbacks over the next 1-3 months; target a 2:1 reward/risk into the next federal contract or platform update, with the thesis that higher-quality revenue and government demand deserve a premium multiple
• Short RGTI into strength or buy downside protection for 3-6 months; the risk/reward worsens if the market begins to question whether new hardware announcements translate into booked revenue rather than science projects
• Pair trade: long IONQ / short RGTI, sized market-neutral, to express relative conviction that commercialization quality matters more than raw quantum ambition over the next 2-4 quarters
• For tactical traders, consider a defined-risk call spread on IONQ around upcoming contract news; this captures upside from sentiment momentum while limiting damage if the sector cools
• Avoid outright long exposure to both names into broad risk-off windows; if high-multiple growth sells off, both can de-rate together even if IONQ is the better business